Liposomal delivery of proteins and peptides

Bibliography

• Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci 2010;99:2557-75
   PubMed Web of Science ®Google Scholar
• Swaminathan J, Ehrhardt C. Chapter 14 - Liposomes for pulmonary drug delivery. Control Pulm Drug Deliv 2011;313-34
   Google Scholar
• Storm G, Crommelin DJA. Liposomes: quo vadis? PSTT 1998;1:19-31
   Google Scholar
• Weiner AL. Liposomes for protein delivery: selecting manufacture and development processes. Immunomethods 1994;4:201-9
   PubMedGoogle Scholar
• Mayer LD, Bally MB, Hope MJ, Cullis PR. Techniques for encapsulating bioactive agents into liposomes. Chem Phys Lipids 1986;40:333-45
   PubMed Web of Science ®Google Scholar
• Ulrich AS. Biophysical aspects of using liposomes as delivery vehicles. Biosci Rep 2002;22:129-50
   PubMed Web of Science ®Google Scholar
• Stark B, Andreae F, Mosgoeller W, Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation. Eur J Pharm Biopharm 2008;70:153-64
   PubMed Web of Science ®Google Scholar
• Adibzadeh M, Weder HG, Rehbein A, Activity of liposomal interleukin-2 in vitro. Mol Biother 1992;4:24-8
   PubMedGoogle Scholar
• Kato Y, Hosokawa T, Hayakawa E, Ito K. Influence of liposomes on tryptic digestion of insulin II. Bio Pharm Bull 1993;16:740-4
   PubMed Web of Science ®Google Scholar
• Corona-Ortega T, Rangel-Corona R, Hernandez-Jimenez M, Characterisation of cationic liposomes having IL-2 expressed on their external surface and their affinity to cervical cancer cells expressing the. IL-2 receptor. J Drug Target 2009;17:496-501
   PubMed Web of Science ®Google Scholar
• Law SL, Shih CL. Characterisation of calcitonin-containing liposome formulations for intranasal delivery. J Microencapsul 2001;18:211-21
   PubMed Web of Science ®Google Scholar
• Hwang SH, Maitani Y, Qi X, Remote loading of diclofenac, insulin and fluorescein isothiocyanate labelled insulin into liposomes by pH and acetate gradient methods. Int J Pharm 1999;179:85-95
   PubMed Web of Science ®Google Scholar
• Hwang SH, Maitani Y, Takayama K, Nagai T. High entrapment of insulin and bovine serum albumin into neutral and positively-charged liposomes by the remote loading method. Chem Pharm Bull (Tokyo) 2000;48:325-9
   PubMed Web of Science ®Google Scholar
• Immordino ML, Dosio F, Cattel L. Stealth liposome: review of the basic science, rationale and clinical applications, existing and potential. Int J Nanomed 2006;1(3):297-315
   PubMed Web of Science ®Google Scholar
• Park S, Choi SG, Davaa E, Park J. Encapsulation enhancement and stabilisation of insulin in cationic liposomes. Int J Pharm 2011;415:267-72
   PubMed Web of Science ®Google Scholar
• Kedar E, Gur H, Babai I, Delivery of cytokines by liposomes: hematopoietic and immunomodulatory activity of interleukin-2 encapsulated in conventional liposomes and in long circulating liposomes. J Immunother 2000;23:131-45
   PubMed Web of Science ®Google Scholar
• Arien A, Tolume-Henry N, Dupuy B. Cholate-induced disruption of calcitonin-loaded liposomes: formation of trypsin-resistant lipid-calcitonin-cholate complexes. Pharm Res 1995;12:1289-92
   PubMed Web of Science ®Google Scholar
• Stark B, Debbage P, Andreae F, Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. Biochim Biophys Acta 2007;1768:705-14
   PubMed Web of Science ®Google Scholar
• Neville ME, Boni LT, Pflug LE, Biopharmaceutics of liposomal interleukin-2, Oncolipin. Cytokine 2000;12:1691-701
   PubMed Web of Science ®Google Scholar
• Joffret ML, Morgeaux S, Laclerc C, Enhancement of interleukin-2 activity by liposomes. Vaccine 1990;8:385-9
   PubMed Web of Science ®Google Scholar
• Degim Z, Unal N, Essiz D, Abbasoglu U. The effect of various liposome formulations on insulin penetration across Caco-2 cell monolayer. Life Sci 2004;75:2819-27
   PubMed Web of Science ®Google Scholar
• Maitani Y, Asano S, Takahashi S, Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits. Chem Pharm Bull (Tokyo) 1992;40:1569-72
   PubMed Web of Science ®Google Scholar
• Song K, Chung S, Shim C. Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts. J Control Release 2005;106:298-308
   PubMed Web of Science ®Google Scholar
• Khanna C, Waldrep JC, Anderson PM, Nebulised interleukin-2 liposomes: aerosol characteristics and biodistribution. J Pharm Pharmacol 1997;49:960-71
   PubMed Web of Science ®Google Scholar
• Kim ST, Lee K, Park H, Topical delivery of interleukin-13 antisense oligonucleotides with cationic elastic liposome for the treatment of atopic dermatitis. J Gene Med 2009;11:26-37
   PubMed Web of Science ®Google Scholar
• Mayer A, Andratschke M, Pauli C, Liposomal transfection of squamous carcinoma cells of the head and neck with IL-2 and B7 plasmids including an autologous immune response in vitro. Anticancer Res 2005;25:3917-23
   PubMed Web of Science ®Google Scholar
• Available from: http://www.tarsatherapeutics.com/Products/calcitonin.html
   Google Scholar
• Available from: www.emisphere.com/pdfs/Drug_Dlvy_Techy_QA_May-08.pdf
   Google Scholar
• Available from: http://www.rttnews.com/1733477/emisphere-says-second-phase-iii-study-of-oral-calcitonin-did-not-meet-endpoints.aspx
   Google Scholar
• Hess DR. Nebuliser: principle and performance. Respir Care 2000;45:609-22
   PubMedGoogle Scholar
• Kling J. Inhaled insulin's last gasp? Nat Biotech 2008;26:479-80
   PubMed Web of Science ®Google Scholar
• Available from: www.pharma.us.novartis.com/product/pi/pdf/miacalcin_nasal.pdf
   Google Scholar
• Kumar R, Philip A. Modified transdermal technologies: breaking the barriers of drug permeation via the skin. Trop J Pharm Res 2007;6:633-44
   Web of Science ®Google Scholar
• Jain N, Talegonkar S, Jain NK. New ways to enter the blood stream: emerging strategies in transdermal drug delivery. Pharm Rev 2004;41-59
   Google Scholar
• Available from: http://www.dietpillswatchdog.com/are-diet-patches-as-effective-as-diet-pills/
   Google Scholar
• Diociaiuti M, Polzi LZ, Valvo L, Calcitonin forms oligomeric pore-like structures in lipid membranes. Biophys J 2006;91:2275-81
   PubMed Web of Science ®Google Scholar
• Bradshaw JP. Phosphatidylglycerol promotes bilayer insertion of salmon calcitonin. Biophys J 1997;72:2180-6
   PubMed Web of Science ®Google Scholar
• Ntimenou V, Mourtas S, Christodoulakis EV, Stability of protein-encapsulating DRV liposomes after freeze-drying: a study with BSA and t-PA. J Liposome Res 2006;16:403-16
   PubMed Web of Science ®Google Scholar
• Koromila G, Michanetzis GP, Missirlis YF, Antimisiaris SG. Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: effect on haemocompatibility. Biomaterials 2006;27:2525-33
   PubMed Web of Science ®Google Scholar
• Vangala A, Bramwell VW, McNeil S, Comparison of vesicle based antigen delivery systems for delivery of hepatitis B surface antigen. J Control Release 2007;119:102-10
   PubMed Web of Science ®Google Scholar
• Antimisiaris SG. Preparation of DRV liposomes. Methods Mol Biol 2010;605:51-75
   PubMedGoogle Scholar
• Stevenson RW, Patel HM, Parsons JA, Ryman BE. Prolonged hypoglycaemic effect in diabetic dogs due to subcutaneous administration of insulin in liposomes. Diabetes 1982;31:506-11
   PubMed Web of Science ®Google Scholar
• Gao XP, Noda Y, Rubinstein I, Paul S. Vasoactive intestinal peptide encapsulated in liposomes: effects on systemic arterial blood pressure. Life Sci 1994;54:PL247-52
   PubMed Web of Science ®Google Scholar
• Refai E, Jonsson C, Andersson M, Biodistribution of liposomal 131I-VIP in rat using gamma camera. Nucl Med Biol 1999;26:931-6
   PubMed Web of Science ®Google Scholar
• Konno H, Maruo Y, Matin AF, Effect of liposomal interleukin-2 on ascites-forming rat hepatoma. J Surg Oncol 1992;51:33-7
   PubMed Web of Science ®Google Scholar
• Cao X, Wang Q, Ju DW, Efficient inducation of local and systemic antitumour immune response by liposome-mediated intratumoral co-transfer of interleukin-2 gene and interleukin-6 gene. J Exp Clin Cancer Res 1999;18:191-200
   PubMed Web of Science ®Google Scholar
• Kanaoka E, Takahashi K, Yoshikawa T, Continuous release of interleukin-2 from liposomal IL-2 (mixture of interleukin-2 and liposomes) after subcutaneous administration to mice. Drug Dev Ind Pharm 2003;29:1149-53
   PubMed Web of Science ®Google Scholar
• Rangel-Corona R, Corona-Ortega T, del Rio-Ortiz I, Cationic liposomes bearing IL-2 on their external surface induced mice leukocytes to kill human cervical cancer cells in vitro and significantly reduced tumour burden in immunodepressed mice. J Drug Target 2011;19:79-85
   PubMed Web of Science ®Google Scholar
• Kabay B, Kocaefe YC, Baykal A, Liposome-mediated intraperitoneal interleukin-10 gene transfer increases survival in cecal litigation and puncture model of sepsis. Shock 2006;26:37-40
   PubMed Web of Science ®Google Scholar
• Petkowicz J, Byra A, Szumilo T. The hypoglycaemic response of diabetic rats to insulin-liposomes. Acta Physiol Pol 1990;41:97-103
   PubMedGoogle Scholar
• Kanaoka E, Takahashi K, Yoshikawa T, A novel and simple type of liposome carrier for recombinant interleukin-2. J Pharm Pharmacol 2001;53:295-302
   PubMed Web of Science ®Google Scholar
• Fukunaga M, Miller MM, Hostetler KY, Deftos LJ. Liposome entrapment enhances the hypocalcaemic action of parenterally administered calcitonin. Endocrinology 1984;115:757-61
   PubMed Web of Science ®Google Scholar
• Cabanes A, Even-Chen S, Zimberoff J, Enhancement of anti-tumour activity of polyethylene glycol-coated liposomal doxorubicin with soluble and liposomal interleukin-2. Clin Cancer Res 1999;5:687-93
   PubMed Web of Science ®Google Scholar
• Kim A, Yun M, Oh Y, Pharmacodynamics of insulin in polyethylene glycol-coated liposomes. Int J Pharm 1999;180:75-81
   PubMed Web of Science ®Google Scholar
• Rubinstein I, Ikezaki H, Onyuksel H. Intratracheal and subcutaneous liposomal VIP normalises arterial pressure in spontaneously hypertensive hamsters. Int J Pharm 2006;316:144-7
   PubMedGoogle Scholar
• Kedar E, Braun E, Rutkowski Y, Delivery of cytokines by liposomes. II. Interleukin-2 encapsulated in long-circulating sterically stabilised liposomes: immunomodulatory and anti-tumour activity in mice. J Immunother Emphasis Tumour Immunol 1994;16:115-24
   PubMed Web of Science ®Google Scholar
• Gursel M, Gregoriadis G. The immunological co-adjuvant action of liposomal interleukin-2: the role of mode of localisation of the cytokine and antigen in the vesicles. J Drug Target 1997;5:93-8
   Web of Science ®Google Scholar
• Johnston D, Reynolds SR, Bystryn J. Interleukin-2/liposomes potentiate immune responses to a soluble protein cancer vaccine in mice. Cancer Immunol Immunother 2006;55:412-19
   PubMed Web of Science ®Google Scholar
• Duits AJ, van Puijenbroek A, Vermeulen H, Immunoadjuvant activity of a liposomal IL-6 formulation. Vaccine 1993;11:777-81
   PubMed Web of Science ®Google Scholar
• Gursel M, Gregoriadis G. Interleukin-15 acts as an immunological co-adjuvant for liposomal antigen in vivo. Immunol Lett 1997;55:161-5
   PubMed Web of Science ®Google Scholar
• Dhillon NK, Dhillon S, Chebloune Y, Therapy of ‘SHIV' infected macaques with liposomes delivering antisense interleukin-4 DNA. AIDS 2006;20:1125-30
   PubMed Web of Science ®Google Scholar
• Simpson-Abelson MR, Purohit VS, Pang WM, IL-12 delivered intratumorally by multilamellar liposomes reactivates memory T cells in human tumour microenvironments. Clin Immunol 2009;132:71-82
   PubMed Web of Science ®Google Scholar
• Charoensit P, Kawakami S, Higuchi Y, Enhanced growth inhibition of metastatic lung tumours by intravenous injection of ATRA-cationic liposome/IL-12 pDNA complexes in mice. Cancer Gene Ther 2010;17:512-22
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Kawada J. Effects of oral administration of positively charged insulin liposomes on alloxan diabetic rats: preliminary study. Endocrinol Jpn 1979;26:337-44
   PubMedGoogle Scholar
• Kisel MA, Kulik LN, Tsybovsky IS, Liposomes with phosphatidylethanol as a carrier for oral delivery of insulin: studies in the rat. Int J Pharm 2001;216:105-14
   PubMed Web of Science ®Google Scholar
• Choudhari KB, Labhasetwar V, Dorle AK. Liposomes as a carrier for oral administration of insulin: effect of formulation factors. J Microencapsul 1994;11:319-25
   PubMed Web of Science ®Google Scholar
• Muramatsu K, Maitani Y, Nagai T. Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats. Bio Pharm Bull 1996;19:1055-88
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes. Pharm Res 1996;13:896-901
   PubMed Web of Science ®Google Scholar
• Iwanaga K, Ono S, Narioka K, Application of surface-coated liposomes for oral delivery of peptide: effects of coating the liposome's surface on the GI transit of insulin. J Pharm Sci 1999;88:248-52
   PubMed Web of Science ®Google Scholar
• Ramadas M, Paul W, Dileep KJ, Lipoinsulin encapsulated alginate-chitosan capsules: intestinal delivery in diabetic rats. J Microencapsul 2000;17:405-11
   PubMed Web of Science ®Google Scholar
• Wu ZH, Ping QN, Wei Y, Lai JM. Hypoglycaemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacol Sin 2004;25:966-72
   PubMed Web of Science ®Google Scholar
• Degim IT, Gumusel B, Degim Z, Oral administration of liposomal insulin. J Nanosci Nanotechnol 2006;6:2945-9
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Matsui Y, Yamamoto H, Kawashima Y. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats. J Control Release 2003;86:235-42
   PubMed Web of Science ®Google Scholar
• Thongborisute J, Takeuchi H, Yamamoto H, Kawashima Y. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery. Pharmazie 2006;61:106-11
   PubMed Web of Science ®Google Scholar
• Das N, Basu MK, Das MK. Oral application of insulin encapsulated liposomes. Biochem Int 1988;16:983-9
   PubMedGoogle Scholar
• Goto T, Morishita M, Nishimura K, Novel mucosal insulin delivery systems based on fusogenic liposomes. Pharm Res 2006;23:384-91
   PubMed Web of Science ®Google Scholar
• Katayama K, Kato Y, Onishi H, Double liposomes: hypoglycaemic effects of liposomal insulin on normal rats. Drug Dev Ind Pharm 2003;29:725-31
   PubMed Web of Science ®Google Scholar
• Yamabe K, Kato Y, Onishi H, Machida Y. Potentiality of double liposomes containing salmon calcitonin as an oral dosage form. J Control Release 2003;89:429-36
   PubMed Web of Science ®Google Scholar
• Ebato Y, Kato Y, Onishi H, In vivo efficacy of a novel double liposome as an oral dosage form of salmon calcitonin. Drug Devel Res 2003;58:253-7
   Web of Science ®Google Scholar
• Suzuki H, Noda Y, Paul S, Encapsulation of vasoactive intestinal peptide into liposomes: effects on vasodilatation in vivo. Life Sci 1995;57:1451-7
   PubMed Web of Science ®Google Scholar
• Suzuki H, Noda Y, Gao XP, Encapsulation of VIP into liposomes restores vasorelaxation in hypertension in situ. Am J Physiol 1996;271:H282-7
   PubMed Web of Science ®Google Scholar
• Sejourne F, Suzuki H, Alkan-Onyuksel H, Mechanisms of vasodilatation elicited by VIP in sterically stabilised liposomes in vivo. Am J Physiol 1997;273(1-2):R287-92
   PubMed Web of Science ®Google Scholar
• Ikezaki H, Paul S, Alkan-Onyuksel H, Vasodilatation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch. Am J Physiol 1998;275:R56-62
   PubMed Web of Science ®Google Scholar
• Ikezaki H, Onyuksel H, Rubinstein I. Liposomal VIP attenuates phenylephrine and ANG II induced vasoconstriction in vivo. Am J Physiol 1998;275:R588-95
   PubMed Web of Science ®Google Scholar
• Onyuksel H, Ashok B, Dagar S, Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity. Peptides 2003;24:281-6
   PubMed Web of Science ®Google Scholar
• Huang Y, Wang C. Pulmonary delivery of insulin by liposomal carriers. J Control Release 2006;113:9-14
   PubMed Web of Science ®Google Scholar
• Bi R, Shao W, Wang Q, Zhang N. Spray-freeze-dried dry powder inhalation of insulin-loaded liposomes for enhanced pulmonary delivery. J Drug Target 2008;16:639-48
   PubMed Web of Science ®Google Scholar
• Khanna C, Hasz DE, Klausner JS, Anderson PM. Aerosol delivery of interleukin-2 liposomes is non-toxic and biologically effective: canine studies. Clin Cancer Res 1996;2:721-34
   PubMed Web of Science ®Google Scholar
• Karathanasis E, Bhavane R, Annapragada AV. Triggered release of inhaled insulin from the agglomerated vesicles: pharmacodynamic studies in rats. J Control Release 2006;113:117-27
   PubMed Web of Science ®Google Scholar
• Karathanasis E, Bhavane R, Annapragada AV. Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats. Int J Nanomedicine 2007;2:501-13
   PubMed Web of Science ®Google Scholar
• Khanna C, Anderson PM, Hasz DE, Interleukin-2 liposome inhalation therapy is safe and effective for dogs with spontaneous pulmonary metastases. Cancer 1997;79:1409-21
   PubMed Web of Science ®Google Scholar
• Skubitz KM, Anderson PM. Inhalational interleukin-2 liposomes for pulmonary metastases: a phase I clinical trial. Anticancer Drugs 2000;11:555-63
   PubMed Web of Science ®Google Scholar
• Ten RM, Anderson PM, Zein NN, Interleukin-2 liposomes for primary immune deficiency using the aerosol route. Int Immunopharmacol 2002;2:333-44
   PubMed Web of Science ®Google Scholar
• Chono S, Fukuchi R, Seki T, Morimoto K. Aerosolised liposomes with dipalmitoylphosphatidylcholine enhance pulmonary insulin delivery. J Control Release 2009;137:104-9
   PubMed Web of Science ®Google Scholar
• Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta 1998;1408:79-89
   PubMed Web of Science ®Google Scholar
• Muramatsu K, Maitani Y, Takayama K, Nagai T. The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits. Drug Dev Ind Pharm 1999;25:1099-105
   PubMed Web of Science ®Google Scholar
• Chen M, Li X, Zhou Y, Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery. Peptides 2009;30:1288-95
   PubMed Web of Science ®Google Scholar
• Law SL, Huang KJ, Chou VHY, Cherng JY. Enhancement of nasal absorption of calcitonin loaded in liposomes. J Liposome Res 2001;11:165-74
   PubMed Web of Science ®Google Scholar
• Jain AK, Chalasani KB, Khar RK, Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. J Drug Target 2007;15:417-27
   PubMed Web of Science ®Google Scholar
• du Plessis LH, Lubbe J, Strauss T, Kotze AF. Enhancement of nasal and intestinal calcitonin delivery by the novel pheroid fatty acid based delivery system and by N-trimethyl chitosan chloride. Int J Pharm 2010;385:181-6
   PubMed Web of Science ®Google Scholar
• Abraham E, Shah S. Intranasal immunisation with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response. J Immunol 1992;149:3719-26
   PubMed Web of Science ®Google Scholar
• Lajavardi L, Bochot A, Camelo S, Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal peptide encapsulated in liposomes. Invest Ophthalmol Vis Sci 2007;48:3230-8
   PubMed Web of Science ®Google Scholar
• Camelo S, Lajavardi L, Bochot A, Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats. Mol Vis 2007;13:2263-74
   PubMed Web of Science ®Google Scholar
• Camelo S, Lajavardi L, Bochot A, Protective effect of intravitreal injection of vasoactive intestinal peptide-loaded liposomes on experimental autoimmune uveoretinitis. J Ocul Pharmacol Ther 2009;25:9-21
   PubMed Web of Science ®Google Scholar
• Lajavardi L, Camelo S, Agnely F, New formulation of vasoactive intestinal peptide using liposomes in hyaluronic gel for uveitis. J Control Release 2009;139:22-30
   PubMed Web of Science ®Google Scholar
• Guo J, Ping Q, Zhang L. Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv 2000;7:113-16
   PubMed Web of Science ®Google Scholar
• Li J, Li X, Zhang Y, Gene therapy for psoriasis in the K14-VEGF transgenic mouse model by topical transdermal delivery of interleukin-4 using ultradeformable cationic liposome. J Gene Med 2010;12:481-90
   PubMed Web of Science ®Google Scholar
• Kajimoto K, Yamamoto M, Watanabe M, Noninvasive and persistent transfollicular drug delivery system using a combination of liposomes and iontophoresis. Int J Pharm 2011;403:57-65
   PubMed Web of Science ®Google Scholar
• Suzuki R, Namai E, Oda Y, Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 2010;142:245-50
   PubMed Web of Science ®Google Scholar